“…Similarly, in hypoproteinemic states such as nephrotic syndrome, the risk of fibrate-induced myopathy is increased (17,18), because less protein is available to bind the active metabolites, thus increasing the levels of free active drug (13). Hypothyroidism is also believed to increase the risk of development of myopathy in association with fibrates (19)(20)(21)(22). There was no clinical evidence of hypothyroidism in any of our patients, and one (patient 1, who developed rhabdomyolysis) had documented normal thyroid function tests 6 months previously.…”